Status:
NOT_YET_RECRUITING
Virtual Reality for Anxiolysis and Pharmacological Sparing
Lead Sponsor:
Ciusss de L'Est de l'Île de Montréal
Collaborating Sponsors:
Paperplane Therapeutics
Conditions:
Virtual Reality
Propofol
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The goal of this clinical trial is to learn if virtual reality can reduce propofol requirements in adult, female patients undergoing elective breast surgery under regional anesthesia. The main questio...
Detailed Description
Virtual reality (VR) has carved out a growing place for itself in our leisure activities, video games and even in medicine. Recent studies show that VR can reduce anxiety and pain in patients undergoi...
Eligibility Criteria
Inclusion
- Fully consented female patients above the age of 18 years;
- Undergoing elective, awake, breast surgery performed under paravertebral block.
Exclusion
- Hearing or visual impairment;
- History of epilepsy, seizure or severe dizziness;
- Severe mental impairment;
- Recent eye or facial surgery or wounds;
- Inability to use the VR hand controller.
Key Trial Info
Start Date :
September 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06522711
Start Date
September 1 2024
End Date
September 1 2026
Last Update
July 26 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maisonneuve-Rosemont Hospital - CIUSSS de l'Est de l'Île de Montréal
Montreal East, Quebec, Canada, H1T2M4